Quick summary: Lumi Lash: Unlicensed product with ingredient on prescription drug list.. Date: 2022-08-25.
Lumi Lash: Unlicensed product with ingredient on prescription drug list.
2022-08-25
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: Lumi Lash: Unlicensed product with ingredient on prescription drug list.. Date: 2022-08-25.
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
Affected products
Issue
Product sold without market authorization (DIN) in Canada. All affected lots may contain bimatoprost, a prostaglandin analogue, which is listed on the prescription drug list. Test results for Lot 20220331 found the product to contain bimatoprost.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional official information
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.